U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07116772) titled 'Serial Assessment of Fertility Experiences' on July 23.
Brief Summary: The SAFE study is a long-term research project that watches people with sickle cell anemia (SCA) over time. The main goal is to see how a medicine called hydroxyurea affects their growth, puberty, and ability to have children. A second goal is to see how hydroxyurea affects pregnancy outcomes, by comparing people who take the medicine to those who don't.
Study Start Date: July 10, 2023
Study Type: OBSERVATIONAL
Condition:
Sickle Cell Anemia
Recruitment Status: RECRUITING
Sponsor: Children's Hospital Medical Center, Cincinnati
Published by HT Digital Conten...